- Home
- KTCC vs CALC Comparison
KTCC vs CALC Comparison
Compare KTCC & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- CALC
- Stock Information
- Founded
- KTCC 1969
- CALC 2011
- Country
- KTCC United States
- CALC United States
- Employees
- KTCC N/A
- CALC N/A
- Industry
- KTCC Electrical Products
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- CALC Health Care
- Exchange
- KTCC Nasdaq
- CALC Nasdaq
- Market Cap
- KTCC 51.2M
- CALC 44.7M
- IPO Year
- KTCC N/A
- CALC N/A
- Fundamental
- Price
- KTCC $5.86
- CALC $3.90
- Analyst Decision
- KTCC
- CALC Strong Buy
- Analyst Count
- KTCC 0
- CALC 4
- Target Price
- KTCC N/A
- CALC $20.50
- AVG Volume (30 Days)
- KTCC 28.2K
- CALC 23.9K
- Earning Date
- KTCC 10-29-2024
- CALC 11-07-2024
- Dividend Yield
- KTCC N/A
- CALC N/A
- EPS Growth
- KTCC N/A
- CALC N/A
- EPS
- KTCC N/A
- CALC N/A
- Revenue
- KTCC $559,396,000.00
- CALC N/A
- Revenue This Year
- KTCC N/A
- CALC N/A
- Revenue Next Year
- KTCC N/A
- CALC N/A
- P/E Ratio
- KTCC N/A
- CALC N/A
- Revenue Growth
- KTCC N/A
- CALC N/A
- 52 Week Low
- KTCC $3.60
- CALC $1.75
- 52 Week High
- KTCC $6.14
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- KTCC 67.62
- CALC 41.63
- Support Level
- KTCC $5.43
- CALC $4.05
- Resistance Level
- KTCC $5.79
- CALC $4.29
- Average True Range (ATR)
- KTCC 0.37
- CALC 0.33
- MACD
- KTCC -0.01
- CALC -0.05
- Stochastic Oscillator
- KTCC 71.43
- CALC 10.17
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.